Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prof. Afzal Siddiqui
Seattle, Washington, United States
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
PAI Life Sciences is a Seattle-based biotechnology company focused on developing vaccines and therapies for neglected tropical diseases. The company's lead program is SchistoShield, a recombinant protein vaccine for schistosomiasis (snail fever) based on the Sm-p80 antigen discovered by Prof. Afzal Siddiqui at Texas Tech University Health Sciences Center. PAI Life Sciences is currently advancing SchistoShield through Phase 1 clinical trials with significant support from the Bill & Melinda Gates Foundation and the National Institutes of Health (NIH). In addition to its work on schistosomiasis, the company is developing vaccine candidates for other global health threats, including leishmaniasis and tuberculosis, and provides specialized adjuvants and translational research services.
- Therapeutic areas
- Infectious Diseases
- Modalities
- VaccineRecombinant proteinBiologic
- Industry
- Academic Hospital/University/Research
02
Partnerships
Bill & Melinda Gates FoundationNational Institute of Allergy and Infectious Diseases (NIAID)Texas Tech University Health Sciences Center (TTUHSC)Infectious Disease Research Institute (IDRI)International Vaccine Institute (IVI)
Beyond the preview
Go deeper on Prof. Afzal Siddiqui.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Prof. Afzal Siddiqui.